The London and Berlin-based startup, Medbelle, has raised $7 million in a recent Series A funding for its “end to end platform” for medical procedures.
The round of funding was led by Signals Venture Capital, which is the VC fund of Signals Induna- a major German health insurer. The funding also included participation from Mutschler Ventures, Talis Capital, Cavalry Ventures and IBB. Medbelle was founded by Leander de Laporte and Daniel Kolb in 2016 after the pair had rejected jobs at Rocket Internet. Since its inception, Medbelle has set out to digitise the patient journey. Its goal is to provide medical treatments to the patients in a more modern, convenient as well as consumer-centric way. Often compared to a ‘digital hospital’, Medbelle allows its patients to book a range of medical services and procedures via its web and app-based platform.
The array of services offered currently includes bariatrics, cosmetics, and ophthalmology. Plans are underway to include orthopedics as well as fertility treatment. Presently, Medbelle only offers its services to private patients, but it has shown interest in working with the UK’s National Health Service besides public and private health insurance providers in order to expand its reach.
Medbelle’s co-founder shares his views on digital hospital
De Laporte explained that it is their vision to create a world wherein all patients can navigate their treatment journey digitally while also receiving personal care at the click of a button. He also said that medical professionals and healthcare providers today lack the tools in order to operate efficiently, which eventually results in a lot of frustration, operational hiccups, and pointless healthcare costs.
Medbelle’s digital offering, consisting of the Medbelle platform, Medbelle Care as well as Medbelle Operating System, is attempting to give patients more control over their provision while also providing the tools to the professionals for covering the entire treatment journey of the patient.